Showing 1,081 - 1,100 results of 1,171 for search 'antibody effect function', query time: 0.12s Refine Results
  1. 1081
  2. 1082

    A review on surface modification of nanofibrous textiles for diverse applications: Focus on medical uses by Rasool Shabanloo, Majid Montazer, Ali Farahani, Nesa Karimi

    Published 2025-01-01
    “…Chemical modification includes functionalization with chemical groups, while biological modification involves coating with proteins, enzymes, or antibodies. …”
    Get full text
    Article
  3. 1083

    Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease by Rukshan Ahamed Mohamed Rafeek, Natkunam Ketheesan, Michael F. Good, Manisha Pandey, Ailin Lepletier

    Published 2025-04-01
    “…In animals injected with rM5 and treated with LD-IL-2, no cardiac functional or histological changes was observed. LD-IL-2 therapy effectively reduced the production of cross-reactive antibodies raised against host proteins and significantly increased regulatory T cells in the mediastinal lymph nodes. …”
    Get full text
    Article
  4. 1084

    Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically... by Nessrin Alomran, Jaffer Alsolaiss, Laura-Oana Albulescu, Edouard Crittenden, Robert A Harrison, Stuart Ainsworth, Nicholas R Casewell

    Published 2021-08-01
    “…Although snakebite can cause a variety of pathologies in victims, haemotoxic effects are particularly common and are typically characterised by haemorrhage and/or venom-induced consumption coagulopathy. …”
    Get full text
    Article
  5. 1085

    Immunogenicity and Safety of 13-valent Conjugated Pneumococcal Vaccine in Patients with Rheumatoid Arthritis by B. T. Batozhargalova, M. P. Kostinov, A. D. Shmitko, G. V. Lukina, D. A. Murtazalieva, E. N. Koltsova, E. V. Zhilyaev

    Published 2024-03-01
    “…Methotrexate (MTX) in RA patients reduced the pneumococcal response and the functional activity of antibodies.…”
    Get full text
    Article
  6. 1086

    Adenoviral-vectored vaccine against Bordetella pertussis fimbrial antigen induces partial protection in a mouse model by Alexa Dierig, Martina Kristof, Christina Dold, Elodie Lesne, Catpagavalli Asokanathan, Luke Blackwell, Barbara Bolgiano, Andrew R. Gorringe, Andrew J. Pollard, Kevin Markey, Christine S. Rollier

    Published 2025-06-01
    “…As a first step to address these issues we developed novel Bordetella pertussis vaccine candidates using viral-vectored vaccine technology with the aim of producing durable functional antibodies that prevent nasal colonization. …”
    Get full text
    Article
  7. 1087

    SARS-CoV-2 Assembly: Gaining Infectivity and Beyond by Harshita Katiyar, Ariana Arduini, Yichen Li, Chen Liang

    Published 2024-10-01
    “…While much attention has been paid to the structure and functions of the viral spike protein and the entry step of viral infection, partly because these are targets for neutralizing antibodies and COVID-19 vaccines, the later stages of SARS-CoV-2 replication, including the assembly and egress of viral progenies, remain poorly characterized. …”
    Get full text
    Article
  8. 1088

    Early Epcoritamab Administration Revives CAR‐T Cells in Relapsed/Refractory B‐Cell Lymphomas by Kensuke Yanashima, Yoshiki Furukawa, Midori Ishii, Shintaro Kinoshita, Yasuharu Hamano, Naoki Watanabe, Yutaka Tsukune, Hajime Yasuda, Jun Ando, Miki Ando

    Published 2025-06-01
    “…ABSTRACT Background Bispecific antibodies are effective for relapsed/refractory B‐cell lymphoma patients even after CAR‐T therapy. …”
    Get full text
    Article
  9. 1089

    Targeting Death Receptor 5 (DR5) for the imaging and treatment of primary bone and soft tissue tumors: an update of the literature by Zakareya Gamie, Anja Krippner-Heidenreich, Craig Gerrand, Kenneth Samora Rankin

    Published 2024-09-01
    “…Currently, clinical trials are investigating the effectiveness of DR5 activation using new biological agents, such as bi-specific or tetravalent antibodies, in improving the survival of patients with relapsed or refractory cancers. …”
    Get full text
    Article
  10. 1090

    Development of mRNA–lipid nanoparticle intrabodies against rickettsial infection by Qi Yan, Nan Duan, Mingqun Lin, Wenqing Zhang, Stephen Denton, Yichen Zhong, Yizhou Dong, Yasuko Rikihisa

    Published 2025-08-01
    “…Abstract Background Rickettsiosis is among the deadliest vector-borne infectious diseases worldwide, in part because rickettsiae replicate within human cells, where antibodies and most drugs cannot effectively reach this obligatory intracellular pathogen. …”
    Get full text
    Article
  11. 1091

    Harnessing the Therapeutic Potential of Th17 Cells by Jonas Bystrom, Taher E. Taher, M. Sherwan Muhyaddin, Felix I. Clanchy, Pamela Mangat, Ali S. Jawad, Richard O. Williams, Rizgar A. Mageed

    Published 2015-01-01
    “…In addition, treatment with antibodies to IL-17 is effective in treating patients with psoriasis, psoriatic arthritis, and refectory rheumatoid arthritis. …”
    Get full text
    Article
  12. 1092

    Immunotherapy of malignant gliomas: a modern view on the problem by А. А. Pichugin, R. R. Kovyazina, А. Trondin, А. G. Alekseev, P. B. Kopnin, T. V. Gessel, S. V. Boichuk

    Published 2024-12-01
    “…These drugs might be effective in treatment of malignant gliomas overexpressing the molecules that suppress immune cells functions. …”
    Get full text
    Article
  13. 1093

    Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats by Cenrong Wang, Xin Tang, Xin Tang, Chenghan Jiang, Yu Zhang, Bo Han, Yi Sun, Jianfeng Guo, Hanyu Peng, Zihan Wang, Yipeng Wang, Jialu Zhang, Yong Zhang, Yong Zhang, Chunlai Jiang, Chunlai Jiang, Chunlai Jiang

    Published 2025-02-01
    “…Naked mRNA vaccines were functional, but less effective than mRNA-LNP vaccines.DiscussionThe above results suggest that RBD3-Fc vaccines are safe and immunogenic and NFIS can be used as an alternative to needles/syringes for the inoculation of mRNA-LNP vaccines to elicit robust systematic immune responses.…”
    Get full text
    Article
  14. 1094

    Size-dependent aggregation of erythrocytes by low molecular weight hyaluronic acids of different sizes: bioactivity and quality control potential by Xinyue Ma, Xiao Wang, XiaoXiao Jia, Jessica H. Hui, Joshua H. Shofaro, Ran Tao, Mizhou Matthew Hui

    Published 2025-04-01
    “…IntroductionHyaluronic acid (HA) is a crucial biological molecule whose diverse functions are strongly influenced by its molecular weight. …”
    Get full text
    Article
  15. 1095

    CDK2 inhibition sensitizes anthracycline-induced immunogenic cell death and enhances the efficacy of anti-PD-1 therapy by Yu Chen, Wancheng Liu, Qiaomei Cai, Chaohu Pan, Zhenghao Yin, Yijiao Tang, Zhixu He, Genhong Cheng, Liping Shu, Liping Shu

    Published 2025-06-01
    “…DiscussionThis study not only suggests that CDK2 inhibition improves the outcome of chemotherapy by enhancing the type-1 interferon response but also investigates the synergistic effects of CDK2 inhibition with MTX or anti-PD-1 antibodies in immunocompetent mice.…”
    Get full text
    Article
  16. 1096

    Duck plague virus UL47 gene affects the release and cell-to-cell spread of the virus and its deletion strains can provide strong protection for ducks by Yuxi Cui, Siyu Chen, Mingshu Wang, Wei Zhang, Qiao Yang, Xumin Ou, Di Sun, Yu He, Bin Tian, Zhen Wu, Shaqiu Zhang, Juan Huang, Ying Wu, Xinxin Zhao, Dekang Zhu, Shun Chen, Mafeng Liu, Renyong Jia, Anchun Cheng

    Published 2025-06-01
    “…The absence of the DPV UL47 gene significantly reduced the virulence of the virus but maintained immunogenicity and immune efficacy, thereby inducing the production of DPV-specific antibodies to resist strong attack by DP. These findings offer valuable insights into the functional characterization of the UL47 gene and the development of an attenuated vaccine based on this gene. …”
    Get full text
    Article
  17. 1097
  18. 1098

    Dynamic maternal synthesis and segregation of the germ plasm organizer, Bucky ball, in chicken oocytes and follicles by Sabine Klein, Roland Dosch, Sven Reiche, Wilfried A. Kues

    Published 2024-11-01
    “…Previously, we proposed the chicken-specific Bucky ball (cBuc) as a functional equivalent of the zebrafish germ plasm organizer. …”
    Get full text
    Article
  19. 1099
  20. 1100

    Aptamers Binding to c-Met Inhibiting Tumor Cell Migration. by Birgit Piater, Achim Doerner, Ralf Guenther, Harald Kolmar, Bjoern Hock

    Published 2015-01-01
    “…In normal conditions, the c-Met receptor is activated by its bivalent ligand hepatocyte growth factor (HGF). Also bivalent antibodies can activate the receptor by cross linking, limiting therapeutic applications. …”
    Get full text
    Article